Werewolf Therapeutics (HOWL) Earnings Date & Reports
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
HOWL is expected to report earnings to fall 17.39% to -37 cents per share on May 07
Q1'25
Est.
$-0.38
Q4'24
Missed
by $0.04
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.05
The last earnings report on March 11 showed earnings per share of -46 cents, missing the estimate of -41 cents. With 526.62K shares outstanding, the current market capitalization sits at 35.53M.